The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

Equities research analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Tuesday. The ...

In order to demonstrate the functionality of this concept, we have constructed a large human antibody single-chain fragment (scFv) library using these principles. This library has been ...

The company is also developing a new antibody library in a powerful mammalian cell display platform. Therapeutic candidates raised from the library will be in a commercially relevant ...

Fusion Antibodies announced on Friday that its OptiMAL validation project with the US National Cancer Institute (NCI) was ...